Search results
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 9 hours ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
MDMA drug for PTSD panned by FDA advisers citing trial flaws - The Boston Globe
The Boston Globe· 2 hours agoThe psychedelic drug MDMA failed to get backing from US regulatory advisers to treat a form of...
FDA panel rejects ecstasy to treat PTSD
The Week· 7 hours agoA Food and Drug Administration advisory panel on Tuesday voted against approving the use of MDMA, a psychedelic drug ...
FDA objects to ecstasy for treating PTSD patients
The Washington Times· 7 hours agoA nonbinding Food and Drug Administration panel rejected a proposal to use MDMA, or ecstasy, to treat post-traumatic ...
Moon Surgical secures FDA nod for commercial soft tissue robot
MedTech Dive via Yahoo Finance· 10 hours agoDive Brief: Moon Surgical has obtained clearance from the Food and Drug Administration to sell the...
5 MA residents sick with salmonella poisoning related to cucumbers. What to know
Gannett via AOL· 4 hours agoThe outbreak is believed to be related to batch of cucumbers that the Food and Drug Administration...
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 20 hours agoA U.S. Food and Drug Administration advisory committee will meet Wednesday to recommend a COVID-19...
Psychedelic stocks tanked after MDMA-assisted therapy for PTSD had a setback
Quartz· 7 hours agoThe stock of several companies working to develop psychedelic medicines to treat mental disorders...
JD Supra: FDA Finalizes Rule to Assert Authority Over Laboratory Developed Tests
JD Supra· 6 hours agoThe Food and Drug Administration (FDA) published its long-awaited Final Rule that will regulate laboratory developed ...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 hours agoThe 16-member panel, which gathered four previous times since 2022, unanimously voted for a shot...